First Republic Capital

FSD Pharma and SciCann Therapeutics Launch Cardiovascular Research Program in Tel Aviv University

TORONTO, Sept. 23, 2018  FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) is pleased to announce the launch of a comprehensive sponsored research program in Tel Aviv University together with its strategic R&D partner, SciCann Therapeutics Inc. (“SciCann”), focused on the cardiovascular disease field. The new research program is aimed

FSD Pharma Inc. Announces $7.5 Million Dollar at $1 Per Share Investment as Part of Existing Strategic Alliance with Auxly Cannabis Group Inc.

TORONTO, Sept. 20, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) is pleased to announce that pursuant to the approved construction and development budget announced on July 3, 2018 (Link), Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly”) has made an equity investment into the Company at $1.00 per Class B Subordinate

FSD Pharma Signs Collaboration and Profit Sharing Agreement with Canntab for Production and Market of Oral Dose Delivery Platforms

TORONTO, Sept.18, 2018 /PRNewswire/ – FSD Pharma Inc. (CSE: HUGE) (OTC :FSDDF ) (FRA: 0K9) (“FSD Pharma” or the “Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that it has signed a definitive collaboration and profit sharing

FSD Pharma joins Snipp’s Cannabis Marketing Resource Center

CSE: HUGE OTC: FSDDF FRA: 0K9 TORONTO, Sept. 17, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) today announced that it has joined the Cannabis Marketing Resource Center (“CMRC”) provided by Snipp Interactive Inc. (“Snipp”) (OTCQB: SNIPF; TSX-V: SPN), a global provider of digital marketing promotions, rebates and

Bird River Resources Announces Conditional approval from the CSE

Winnipeg, Manitoba (FSCwire) – Bird River Resources Inc. (CSE:BDR) (the “Company”) is pleased to announce that further to its news release dated June 5, 2018 the Company has received conditional approval from the Canadian Securities Exchange (the “CSE”) for its draft comprehensive CSE Form 2A 2018 Listing Statement (“Listing Statement”) and lifting of the temporary

FSD Pharma to Expand into Jamaican Market and Introduce FSD Jamaica

CSE: HUGE OTC: FSDDF FRA: 0K9 TORONTO, Sept. 13, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that it intends to launch a strategic partnership into the Jamaican cannabis market as part of its plan to expand internationally. FSD has signed a Letter